21.42500 EUR
2.411
12.68%
Last update Dec 18, 3:33 PM CET
Pre-market
Day range
21.42500
22.18000
Previous close
19.014000
Open
22.18000
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
21.43
2.41
12.68%

Statistics

Valuation metrics
Market cap
3.51B
Enterprise value
2.35B
Trailing P/E (ttm)
71.55
Forward P/E
PEG ratio
Price/Sales (ttm)
3.57
Price/Book (mrq)
8.22
Enterprise Value/Revenue
2.71
Enterprise Value/EBITDA
33.51
Overview
Shares outstanding
126.50M
Float
89.57M
Shares short
% Held by insiders
13.64%
% Held by institutions
103.93%
Average volume (10 days)
1
Average volume (90 days)
0
Price summary
52-Week low
16.88
52-Week high
24.26
52-Week change
21.23 125.8%
Beta
0.36
50-Day moving average
19.01
200-Day moving average
19.69
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
4.43%
Operating margin
48.67%
Operational effectiveness
Return on assets
5.13%
Return on equity
14.10%
Income statement
Revenue (ttm)
866.47M
Revenue per share (ttm)
8.09
Quarterly revenue growth (yoy)
133%
Gross profit (ttm)
515.80M
EBITDA
69.97M
Net income to common (ttm)
38.35M
Diluted EPS (ttm)
0.31
Quarterly earnings growth (yoy)
129.19%
Balance sheet
Total cash (mrq)
409.39M
Total cash per share (mrq)
3.80
Total debt (mrq)
405.25M
Total Debt/Equity (mrq)
118.50
Current ratio (mrq)
354.40%
Book value per share (mrq)
2.70
Cash flow
Cash flow statement
67.23M
Levered free cash flow (LFCF)
42.02M
Access /statistics data via our API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 40 minutes

08:19
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).